SCHEMBL6847652

SCHEMBL6847652

O=C1CNCc2ccccc2N1CCCc1ccccc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 6/20 0.53
DRD3 P35462 6/20 0.53
CHRM2 P08172 5/20 0.53
CHRM4 P08173 5/20 0.53
CHRM5 P08912 5/20 0.53
CHRM1 P11229 5/20 0.53
CHRM3 P20309 5/20 0.53
DRD4 P21917 5/20 0.53
ALDH1A1 P00352 2/20 0.49
ALDH2 P05091 1/20 0.49
PKM P14618 1/20 0.49
ALDH3A1 P30838 1/20 0.49
GSK3A P49840 2/20 0.49
GSK3B P49841 2/20 0.49
POLB P06746 1/20 0.44
FAAH O00519 1/20 0.44
MGLL Q99685 1/20 0.44
ADRB2 P07550 2/20 0.44
ADRB1 P08588 2/20 0.44
ADRA1D P25100 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6300376 0.92 CHRM2 (0.52) DRD2DRD3CHRM2CHRM4CHRM5
SCHEMBL9835589 0.87 GSK3A (0.59) ALDH1A1ALDH2PKMALDH3A1GSK3A
SCHEMBL6302300 0.82 POLB (0.65) DRD2DRD3CHRM2CHRM4CHRM5
SCHEMBL6302307 0.81 MAPT (0.50) DRD2DRD3CHRM2CHRM4CHRM5
SCHEMBL6300286 0.77 ATAD2 (0.43) DRD2DRD3CHRM2CHRM4CHRM5
SCHEMBL6300067 0.77 HTR7 (0.40) DRD2DRD3CHRM2CHRM4CHRM5
SCHEMBL6768550 0.77 ALDH1A1 (0.54) DRD3ALDH1A1HTR7HTR1ARAB9A
SCHEMBL6849564 0.77 CHRM2 (0.39) DRD2DRD3CHRM2CHRM4CHRM5
SCHEMBL21257673 0.76 HRH1 (0.56) DRD2DRD3CHRM2CHRM4CHRM5
SCHEMBL31033176 0.75 ALDH1A1 (0.51) DRD2DRD3CHRM2CHRM4CHRM5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6774125-B2 TREATING ALZHEIMER'S DISEASE ELAN PHARMACEUTICALS, INC. 2004-08-10 US disclosed
US-6509331-B1 Bicyclic amides such as 5-('-(2S-hydroxy-3-methylbutyrl)-2S-aminopropyl)amino-7-methyl-5,7-dihydro -6H-dibenz(b,d)azepin-6-one ELAN PHARMACEUTICALS, INC. 2003-01-21 US disclosed